UWO37 Cells

The UWO37 (HPV16) cell line is derived from the tumor cells of a male patient diagnosed with oral tongue cancer and exhibits expression of Human Papillomavirus type 16 (HPV16). This cell line is pivotal for investigations into the molecular mechanisms by which HPV16 contributes to the pathogenesis of head and neck squamous cell carcinoma (HNSCC). By providing a model system that retains the genetic and phenotypic characteristics of the original tumor, UWO37 enables a detailed exploration of viral oncogenesis, interactions between viral proteins and host cell pathways, and the cellular responses to HPV16 integration. Research utilizing the UWO37 cell line focuses on unraveling the complex interplay between HPV16 and cellular machinery, identifying how viral oncogenes such as E6 and E7 contribute to cell transformation and malignancy. This model is also crucial for screening potential pharmacological agents and for developing gene therapy approaches aimed at targeting specific pathways altered by HPV16. Furthermore, the UWO37 cell line serves as a valuable tool for studying the efficacy and safety of new immunotherapeutic strategies, which could lead to enhanced treatment and prevention of HPV-related cancers.